Skip to content

A randomized controlled trial for Wenyang Sanjie Decoction in the treatment of bone metastasis of lung cancer

A randomized controlled trial for Wenyang Sanjie Decoction in the treatment of bone metastasis of lung cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003688
Enrollment
Unknown
Registered
2020-08-25
Start date
2022-10-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bone metastasis of lung cancer

Interventions

Sponsors

Longhua Hospital, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients with primary lung cancer confirmed by cytological or histopathological methods and confirmed by X-ray, CT, MRI, bone ECT, PET/CT and other imaging examinations; (2) TCM syndrome differentiation is Yangxu Tanning; (3) Patients with bone metastasis who could not receive chemoradiotherapy within 1 month, or over 1 month after the end of chemoradiotherapy; (4) Aged > 18 years and = 60, life expectancy >= 6 months; (6) Allergic to traditional Chinese medicine, zoledronic acid and topical ointment; (7) Understand and agree to receive the treatment, and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Pain accompanied by local redness, swelling and fever; (2) Those who apply targeted drug therapy; (3) Patients with severe heart, liver and kidney diseases or a history of mental illness; (4) Poor compliance and incomplete data; (5) Persons with a history of mental illness.

Design outcomes

Primary

MeasureTime frame
Bone metastases change;

Secondary

MeasureTime frame
The quality of life;Progression-free survival;Serum calcium;The degree of pain;Tumor marker;The immune function;Alkaline phosphatase;

Countries

China

Contacts

Public ContactQin Jingru

Longhua Hospital, Shanghai University of Traditional Chinese Medicine

215861506@qq.com+86 15638787869

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026